1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
A finance professor made a startling discovery about the stock market: Over a 90-year span, 96% of all stocks collectively performed no better than risk-free 1-month Treasury bills. After analyzing...
This blue-chip-centric passive investment strategy is simple and successful. But are its imitators even better?
Lipitor, Humira and Advair boosted the bottom lines of Big Pharma companies and their shareholders for years.
More Investing News »